Published in Eye (Lond) on March 20, 2015
Vitreous hemorrhage after plaque radiotherapy for uveal melanoma. Retina (2012) 2.06
Pars plana vitrectomy to repair retinal detachment following brachytherapy for uveal melanoma. Br J Ophthalmol (2013) 2.03
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Arch Ophthalmol (2006) 1.93
Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology (1999) 1.35
Management of posterior uveal melanoma. Surv Ophthalmol (1992) 1.29
Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol (2000) 1.22
Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma. Ophthalmology (2002) 0.95
Current trends in the treatment of ocular melanoma by radiotherapy. Clin Experiment Ophthalmol (2003) 0.91
Predicting local control of choroidal melanomas following ¹⁰⁶Ru plaque brachytherapy. Br J Ophthalmol (2010) 0.89
Pars plana vitrectomy in eyes containing a treated posterior uveal melanoma. Am J Ophthalmol (2003) 0.85
Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma. Retina (2013) 0.84
Safety of pars plana vitrectomy in eyes with plaque-irradiated posterior uveal melanoma. Arch Ophthalmol (2012) 0.83
Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma. Clin Ophthalmol (2013) 0.81